EVALUATION OF A NOVEL, NATURAL LOCUST BEAN GUM AS A SUSTAINED RELEASE AND MUCOADHESIVE COMPONENT OF TIZANIDINE HYDROCHLORIDE BUCCAL TABLETS

  • Harikrishnan Vasudevan Nair ASSISTANT PROFESSOR NATIONAL COLLEGE OF PHARMACY MANASSERY CALICUT
  • Dr.madhusudhan. S M.Pharm,PhD
  • Dr.santhiagu A Doctor of Philosophy (Ph. D) in Biochemical Engineering (2006) - School of Biochemical Engineering Institute of Technology Banaras Hindu University, Varanasi

Abstract

Mucoadhesive polymers that bind to the gastric mucins or epithelial cell surface are useful in drug delivery for the purpose of increasing the intimacy andduration of contact of the drug with the absorbing membrane. Mainly synthetic polymers are in use for this purpose. Probably the biodegradability of thesynthetic polymers is questionable. In the present work mucoadhesive buccal tablets of tizanidine hydrochloride were prepared using locust bean gumthat has better mucoadhesive property than synthetic polymer. The in vitro adhesive and mucoadhesive strength and swelling property of mucoadhesivmaterial locust bean gum were evaluated by Share Stress and Park and Robinson methods. Buccal formulations of tizanidine hydrochloride tablets werprepared using locust bean gum, and thickness, hardness, friability, weight variation, and assay of tablets were tested. The in vitro drug release studof tizanidine hydrochloride exhibited extended drug release profile for tablets prepared. Higuchi and Peppas data reveal that the drug released by nonFickian
diffusion mechanism. The present
study
shows
that formulation
containing 50% locust bean gum have
greater
mucoadhesive
property
than allother
formulation.
Increase
in concentration
of locust bean gum increases
in the bioadhesive
strength
and swelling
ratio
in the 50
mg
of locust bean gum.
Keywords: Mucoadhesive, Tizanidine hydrochloride, Tablets, Locust bean gum.

References

1. Nance PW, Bugaresti J, Shellenberger K, Sheremata W, Martinez-
Arizala A. Efficacy and safety of tizanidine in the treatment of spasticity
in patients with spinal cord injury. North American Tizanidine Study
Group. Neurology 1994;44 11 Suppl 9:S44-51.
2. Wagstaff AJ, Bryson HM. Tizanidine. A review of its pharmacology,
clinical efficacy and tolerability in the management of spasticity
associated with cerebral and spinal disorders. Drugs 1997;53(3):435-52.
3. Moffat AC. Clark’s Isolation and Identification of Drugs. London:
Pharmaceutical Press; 2006. p. 691.
4. Mumtaz AM, Ching HS. Design of a dissolution apparatus suitable
for in situ release study of triamcinolone acetonide from bioadhesive
buccal tablets. Int J Pharm 1995;121:129-39.
5. Bottenberg P, Cleymaet R, de Muynck C, Remon JP, Coomans D,
Michotte Y, et al. Development and testing of bioadhesive, fluoridecontaining
slow-release
tablets
for oral use. J
Pharm
Pharmacol
1991;43(7):457-64.
6. Cafaggi S, Leardi R, Parodi B, Caviglioli G, Russo E, Bignardi G.
Preparation and evaluation of a chitosan salt-poloxamer 407 based
matrix for buccal drug delivery. J Control Release 2005;102(1):159-69.
7. Duchene D, Touchard F, Peppas NA. Pharmaceutical and medical
aspects of bioadhesive systems for drug administration. Drug Dev Ind
Pharm 1988;14:283.
8. El-Samaligy MS, Yahia SA, Basalious EB. Formulation and
evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm
2004;286(1-2):27-39.
9. Mohammed FA, Khede H. Preparation and in vitro/in vivo evaluation
of the buccal bioadhesive propertis of slow - Release tablets containing
Miconazole Nitrate. Drug Dev Ind Pharm 2003;29:321-37.
10. Finn A, Collins J, Voyksner R, Lindley C. Bioavailability and
metabolism of prochlorperazine administered via the buccal and oral
delivery route. J Clin Pharmacol 2005;45(12):1383-90.
11. Nakhat PD, Kondawar AA, Babla IB, Rathi LG, Yeole PG. Studies
on buccoadhesive tablets of terbutaline sulphate. Indian J Pharm Sci
2007;69(4):505-10.
12. Park K, Robinson JR. Bioadhesive polymers as platforms for oral –
Controlled drug delivery: Method to study bioadhesion. Int J Pharm
1984;19:107-27.
13. Costa P, Sousa Lobo JM. Modeling and comparison of dissolution
profiles. Eur J Pharm Sci 2001;13(2):123-33.
14. Peppas NA, Korsmeyer RW. Hydrogels in Medicine and Pharmacy:
Properties and Application. Vol. 1. Boca Raton: CRC; 1986. p. 103-9.
15. Pramod Kumar TM, Shivakumar SG. Novel core in cup buccoadhesive
systems and films of terbutaline sulphate – Development and in vitro
evaluation. AJPS 2006;1:175-87.
16. Chanda R, Mahapatro SK, Roy A, Bahadur S. Development of oral
mucoadhesive tablets of terbutaline sulphate using some natural
materials extracted from Albelmoschus esculeatus and Tamarindus
indica. Res J Pharm Technol 2008;11:46-52.
17. Save T, Shah MU, Ghamande AR, Venkitachalam P. Comparative study
of buccoadhesive formulation and sublingual capsule of nifedipine.
J Pharm Pharmacol 1994;46:192-5.
18. Chen WG, Chi Hwang GC. Adhesive and in vitro release characteristics
of propranolol bioadhesive disc system. Int J Pharm 1992;82:61-6.
19. Yamazaki N, Monma Y, Tanabe T. Effect of propranolol and atenolol on
rat kidney. Nippon Yakurigaku Zasshi 1983;81(5):33-9.
20. Vijayaraghavan C, Vasanthakumar S, Ramakrishnan K. An in vitro and
in vivo evaluation of locust bean gum and chitosan combination as a
carrier for buccal drug delivery. Pharmazie 2008;63(5):112-4.
21. Degim T, Eglen B, Ocak O. A sustained release dosage form of
acyclovir for buccal application: An experimental study in dogs. J Drug
Target 2006;14(1):35-44.
Statistics
251 Views | 492 Downloads
How to Cite
Vasudevan Nair, H., D. S, and D. A. “EVALUATION OF A NOVEL, NATURAL LOCUST BEAN GUM AS A SUSTAINED RELEASE AND MUCOADHESIVE COMPONENT OF TIZANIDINE HYDROCHLORIDE BUCCAL TABLETS”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 6, Nov. 2015, pp. 7-10, https://innovareacademics.in/journals/index.php/ajpcr/article/view/7731.
Section
Review Article(s)